The Aerosol Drug Management Improvement Team

Slides:



Advertisements
Similar presentations
Inhalers The Perfect technique Vicky Walker Clinical Lead for Respiratory Services Sarah Wilson Respiratory Nurse Specialist.
Advertisements

Asthma Medication Administration Marcia Winston, MSN,CPNP,AE-C The Children’s Hospital of Philadelphia Division of Pulmonary Medicine.
1 Pharmacy technician roles in helping clients with respiratory conditions.
Respiratory Prescribing in Tower Hamlets Bill Sandhu Head of Medicines Management, Tower Hamlets Medicines Management Team.
The Least Imperfect Device Karen Meade Clinical Nurse Specialist The Hillingdon Hospital.
Inhaler technique is it important?. Compton et al (2006) Review of evidence from 6 European countries ( Spain, Italy, France, Germany, Netherlands, UK)
Improving Medication Adherence in COPD with an Effective Device Orapan Poachanukoon, MD.
Perform and therapeutic benefit of Using a Nebuliser / Inhaler correctly Devangna Bhatia.
1 British Guideline on the Management of Asthma BTS/SIGN British Guideline on the Management of Asthma, May 2008 Introduction Diagnosis Non-pharmacological.
PK and PD Studies for Systemic Exposure of Locally Acting Drugs Industry View Lester I. Harrison, PhD Division Scientist 3m Pharmaceuticals.
Paediatric Asthma Maria Tracey Paediatric Pharmacist Jane Davis Paediatric Clinical Nurse Specialist CF/Respiratory Royal Alexandra Hospital Paisley.
Impact of Montelukast on Symptoms of Mild-to-Moderate Persistent Asthma and Exercise-Induced Asthma: The ASTHMA Survey The ASTHMA* survey was supported.
VALUE AND RESPONSIBLE RESPIRATORY PRESCRIBING Dr Vince Mak, Consultant Physician, NWLH Trust.
Asthma Education Stanford Pediatrics Sara Federico, MD.
Asthma Management Fine Tuning  Maximum control with minimum medication  Start with mild asthma and work up the scale (BTS/SIGN 2004)
London Respiratory Team Understanding respiratory spend and increasing value: Inhalers and nicotine replacement therapy Responsible Respiratory Prescribing.
Asthma Education in Canada The role of the Canadian Network For Asthma Care (CNAC) R. L. (Bob) Cowie MD Asthma For Africa Congress February 2001.
Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 3 Administration of Aerosolized Agents.
SGA 2003-W SS Slide 1 Capacity of Oral SINGULAIR to Prevent Asthma Exacerbations CApacidad de SIngulair ™ Oral en la Prevencion de Exacerbaciones.
1 Asthma October 30, Weiss, Gergen, & Hodgson (1992)2 Pediatric Statistics Prevalence increasing School absences Estimated as more than 10 million.
Aerosol Therapy and Nebulizers
David P. Arpino, RRT, RPFT ALHE 4060 – Research in Allied Health Dr. Masini August 2, 2007.
Inhalation Devices Heba Abd El-fattah Sabry Pharm D.
HS 4 Respiratory Care.
Asthma Medication and Devices Update Lisa C. Johnson RRT, RCP, BAS, AE-C Pediatric Asthma Program Vidant Medical Center.
MEDICAL DEVICES Asthma Control:. Learning to Monitor and Control Your Asthma Hi there, remember me? I’m Julie, your asthma trainer. Do you remember earlier.
Responsible Respiratory Prescribing
Inhaler technique in COPD management: The cost of getting it wrong Zinc code: UKACL1878da Date of preparation May 2015 AstraZeneca provided funding & reviewed.
Advances in Pediatric Asthma Care Keyvan Rafei, MD, MBA Division Head, Pediatric Emergency Medicine Chairman, Pediatric Asthma Program.
Asthma Guidelines, Diagnosis and Management Alison Hughes Respiratory Specialist Nurse Solent NHS Trust.
Wendy Pigg Practice support Pharmacist/Independent Prescriber
Improving the experience of all Londoners with COPD and minimising the impact of the disease London Respiratory Team Medicines Management Workstream Dr.
YOUR PHARMACY / JOB- TITLE YOUR NAME Respiratory MUR.
Creating Asthma Friendly Schools in Montana A Presentation to School Staff Your Name Your Affiliation.
COMMON ERRORS IN MANAGEMENT OF BRONCHIAL ASTHMA IN A PERIPHERAL HOSPITAL Surgeon Cdr Anuj Singhal Graded Specialist (Med)
Taper DPI FeatureImpact Efficacy Safety Compliance Cost High Efficiency  Equivalent lung dose achieved in- vitro with approximately 50% lower delivered.
Wheeze and Asthma Key Facts and Updates Dr Reena Bhatt, Paediatric Darzi Fellow in Asthma.
Asthma and Small Airway Inflammation
Medicines Optimisation
Use of Inhalers and Nebulizers Staff Training
Comparison of Pharmaceutical Performance
Research where it is most needed National Respiratory Strategy
Effect of gas density on aerosol delivery from a pressurized metered-dose inhaler (pMDI) and jet nebulizer. A. Albuterol was administered via a pMDI and.
Devices, demonstration and discussion
Linda Cherry Community Respiratory Practitioner.
Monitoring asthma in primary care
The Role of Fixed-Dose Dual Bronchodilator Therapy in Treating COPD
Improving Inhaler Technique
Medicines Optimisation
Asthma Annual Reviews Hetal Dhruve Presented by Anh Vu
Respiratory Disorders
Unlocking the Secrets to Maximize Pulmonary Medications
The Modern Management of Asthma: Getting it right Part 2
Chapter 3 Administration of Aerosolized Agents
The Aerosol Drug Management Improvement Team
INHALATION THERAPY FOR ASTHMA AND COPD
AEROSOL THERAPY.
INHALATION THERAPY FOR ASTHMA AND COPD
Spirometry A. H. Mehrparvar, MD Occupational Medicine department
The Aerosol Drug Management Improvement Team
The Aerosol Drug Management Improvement Team
Effects of cysteinyl leukotrienes and leukotriene receptor antagonists on markers of inflammation  Anthony P. Sampson, PhDa, Emilio Pizzichini, MD, PhDb,
The Aerosol Drug Management Improvement Team
The Aerosol Drug Management Improvement Team
The Aerosol Drug Management Improvement Team
The Aerosol Drug Management Improvement Team
Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma  Jennifer.
Asthma Education for Families and HCPs
The Aerosol Drug Management Improvement Team
Presentation transcript:

The Aerosol Drug Management Improvement Team ADMIT Slide Deck 2018

Part 4 Inhaler technique in adults Errors and solutions Chris Corrigan King’s College London School of Medicine, UK

Poor asthma control: the size of the problem

Asthma insights and reality in Europe (AIRE) Rabe KF et al. Eur Respir J 2000;16:802-807

Asthma insights and reality in Europe (AIRE) Rabe KF et al. Eur Respir J 2000;16:802-807

Asthma insights and reality in Europe (AIRE) Rabe KF et al. Eur Respir J 2000;16:802-807

Misuse of pMDIs is common and impairs asthma control Giraud V, Roche N. Eur Respir J 2002;19:246-251

Poor inhaler technique causes asthma attacks Hoskins G et al. Thorax 2000;55:19-24

Guidelines are meant to serve everybody

But in fact serve nobody!

Before increasing therapy, ask yourself… Is the patient using the treatment at all? Is the patient using an inhaler device which he/she is able to use and which suits him/her best? Is the patient using the correct inhalation technique? Has the patient stopped smoking? Have other possible exacerbating factors for asthma been identified and eliminated where possible?

Before increasing therapy, ask yourself… Is the patient using the correct inhalation technique? Is the patient using the treatment at all? Is the patient using an inhaler device which he/she is able to use and which suits him/her best? Has the patient stopped smoking? Have other possible exacerbating factors for asthma been identified and eliminated where possible?

Compliance

Compliance with medication is poor Milgrom H et al. J Allergy Clin Immunol 1996;98:1051-1057 Bender B et al. J Asthma 1998;35:347-350

Pressurised, metered-dose inhalers (pMDIs) Inhaler technique Pressurised, metered-dose inhalers (pMDIs)

Shake the device (becoming less important) pMDIs: key techniques Shake the device (becoming less important) Exhale fully Actuate the device after starting to inhale Inhale slowly Breath hold following inhalation

Co-ordination errors with pMDIs % Patients Triggered during exhalation 0.5 Triggered before exhalation 24.6 Triggered at end of exhalation 18.6 Concluded triggering while holding breath 24.2 Triggered in mouth but inhaled through nose 12.1 Several dosages dispensed during one inhalation 7.9 Other mistakes* 5.1 *Stopping inhalation at the moment of activation Crompton GK et al. Respir Dis 1982;119:101-104

Poor co-ordination reduces lung delivery Good coordinator Bad coordinator Newman SP et al. Thorax 1991;46:712-716

Perfect inhalation with pMDIs Slow and deep inhalation is optimal Inhale at 30 l/min then hold breath for 10 sec Actuation time is not critical (as long as it commences after the slow and deep inhalation) Slow vital inspiratory capacity manoeuvre: 2.5 litres over 5 seconds = 30 l/min Newman SP et al. Eur J Respir Dis Suppl 1982;119:57-65

Most patients inhale too rapidly with pMDIs Good Verbal Verbal + 2T The 2T device Al Showair RAM et al. Chest 2007;131:1776-1782

Slow inhalation is not so critical with fine particles Fast inhalation Usmani OS et al. Am J Respir Crit Care Med 2005;172:1497-1504

Spacer devices Obviate coordination of actuation and inhalation May be bulky and patients often dislike them Slow aerosol transit time and particle size May fit only a single pMDI device Deliver more drug to the lung periphery Do not obviate the necessity for patients to inhale slowly and breath hold Trap larger particles and stop their deposition in the oropharynx May cause excessive loss of the respirable dose if there is excessive delay after actuation, or multiple actuation May be used to guide inspiratory flow rate (whistle devices) May accumulate static electricity, reducing the delivery of particles especially with plastic spacers

Not all spacers are the same Bisgaard H et al. Arch Dis child 1995;73:226-230

Spacers: slow inhalation and breath holding still important BDP HFA with spacer and tidal breathing BDP HFA with deep inspiration and breath hold Roller CM et al. Eur Respir J 2007;29:299-306

Spacers: clinical efficacy pMDI + Aerochamber 12/18 discontinued oral steroids pMDI alone 6/18 discontinued oral steroids Salzman GA & Pyszczynski DR. J Allergy Clin Immunol 1988;81:424-428

Dry powder inhalers (DPIs) Inhaler technique Dry powder inhalers (DPIs)

Make sure the device is primed properly DPIs: key techniques Make sure the device is primed properly Inhale with a fast suck that is as deep and hard as possible from the start

Budesonide Turbohaler® 400 µg DPIs: fast, sharp inhalation is critical Budesonide Turbohaler® 400 µg BDP HFA Autohaler® 100 µg Kamin WES et al. J Aerosol Med 2002;15:65-73

DPIs: successful delivery depends on a threshold inspiratory force Accuhaler®/Diskus® Turbohaler® Broeders MEAC et al. Eur Respir J 2001;18:780-783

Inhaler technique How to improve it

Strategies to improve inhaler technique Choose the right device for the right patient Can they use it? Do they like it? Education, education, education At clinical review Pharmacist-led education of small groups J Asthma 2007;44:57-64 Specialist compliance and technique clinics Respir Care 2004;49;600-605 Training aids Access to information (ADMIT, etc)

Physicians do not know how to use inhalers Hanania NA et al. Chest 1994;105:111-116

Recent current ADMIT activities Video with recommendations for patients “how to use most common devices“ Criteria based inhaler device search database Service tools for medical Professionals Slide kit for medical professionals CD ROM “inhalation Therapy in Asthma” with interactive tools Info flyer for patients Video on “Step consultation of the asthma patient” Disease and therapy based information for patients and Health Care Professionals considering inhalation and device issues available in various languages ADMIT periodic E-Mail Newsletter and ADMIT Annual Newsletter Publications Presentations at Congresses i.e. ERS